Use of real-world evidence in economic assessments of pharmaceuticals in the United States

BACKGROUND: Despite the increasing interest in expanding the use of real-world evidence (RWE) in economic assessments of pharmaceuticals, decision makers face uncertainty about how RWE should be used. OBJECTIVE: To assess the use of RWE in economic assessments of drugs by the Institute for Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Woojung, Dayer, Victoria, Jiao, Boshen, Carlson, Josh J, Devine, Beth, Veenstra, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390921/
https://www.ncbi.nlm.nih.gov/pubmed/33377439
http://dx.doi.org/10.18553/jmcp.2021.27.1.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390921/
https://www.ncbi.nlm.nih.gov/pubmed/33377439
http://dx.doi.org/10.18553/jmcp.2021.27.1.005

Ejemplares similares